A locus for generalized tonic-clonic seizure susceptibility maps to chromosome 10q25-q26

被引:13
作者
Puranam, RS
Jain, S
Kleindienst, AM
Saxena, S
Kim, MK
Changizi, BK
Padma, MV
Andrews, I
Elston, RC
Tiwari, HK
McNamara, JO [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Neurobiol, 401 Bryan Res Bldg,Res Dr,Box 3676, Durham, NC 27710 USA
[2] Duke Univ, Dept Med Neurol, Durham, NC 27710 USA
[3] Duke Univ, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA
[4] All India Inst Med Sci, Ctr Neurosci, New Delhi, India
[5] Case Western Reserve Univ, Dept Epidemiol, Cleveland, OH 44106 USA
[6] Case Western Reserve Univ, Dept Biostat, Cleveland, OH 44106 USA
[7] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA
[8] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
关键词
D O I
10.1002/ana.20598
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Inheritance patterns in twins and multiplex families led us to hypothesize that two loci were segregating in subjects with juvenile myoclonic epilepsy (JME), one predisposing to generalized tonic-clonic seizures (GTCS) and a second to myoclonic seizures. We tested this hypothesis by performing genome-wide scan of a large family (Family 01) and used the results to guide analyses of additional families. A locus was identified in Family 01 that was linked to GTCS (10q25q26). Model-based multipoint analysis of the 10q25-q26 locus showed a logarithm of odds (LOD) score of 2.85; similar results were obtained with model-free analyses (maximum nonparametric linkage [NPL] of 2.71; p = 0.0019). Analyses of the 10q25-q26 locus in 10 additional families assuming heterogeneity revealed evidence for linkage in four families; model-based and model-free analyses showed a heterogeneity LOD (HLOD) of 2.01 (alpha = 0.41) and maximum NPL of 2.56 (P = 0.0027), respectively, when all subjects with GTCS were designated to be affected. Combined analyses of all I I families showed an HLOD of 4.04 (alpha = 0.5 1) and maximum NPL score of 4.20 (p = 0.000065). Fine mapping of the locus defined an interval of 4.45Mb. These findings identify a novel locus for GTCS on 10q25-q26 and support the idea that distinct loci underlie distinct seizure types within an epilepsy syndrome such as JME.
引用
收藏
页码:449 / 458
页数:10
相关论文
共 33 条
[1]   Epilepsies in twins: Genetics of the major epilepsy syndromes [J].
Berkovic, SF ;
Howell, RA ;
Hay, DA ;
Hopper, JL .
ANNALS OF NEUROLOGY, 1998, 43 (04) :435-445
[2]  
BERKOVIC SF, 1993, EPILEPSIA, V34, pS19
[3]   Family study of epilepsy in first degree relatives: data from the Italian Episcreen Study [J].
Bianchi, A ;
Viaggi, S ;
Chiossi, E .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2003, 12 (04) :203-210
[4]  
BIANCHI A, 1993, EPILEPSIA, V34, P819
[5]  
Chen XN, 1999, GENOME RES, V9, P492
[6]   Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy [J].
Cossette, P ;
Liu, LD ;
Brisebois, K ;
Dong, HH ;
Lortie, A ;
Vanasse, M ;
Saint-Hilaire, JM ;
Carmant, L ;
Verner, A ;
Lu, WY ;
Wang, YT ;
Rouleau, GA .
NATURE GENETICS, 2002, 31 (02) :184-189
[7]   Genome scan of idiopathic generalized epilepsy: Evidence for major susceptibility gene and modifying genes influencing the seizure type [J].
Durner, M ;
Keddache, MA ;
Tomasini, L ;
Shinnar, S ;
Resor, SR ;
Cohen, J ;
Harden, C ;
Moshe, SL ;
Rosenbaum, D ;
Kang, H ;
Ballaban-Gil, K ;
Hertz, S ;
Labar, DR ;
Luciano, D ;
Wallace, S ;
Yohai, D ;
Klotz, I ;
Dicker, E ;
Greenberg, DA .
ANNALS OF NEUROLOGY, 2001, 49 (03) :328-335
[8]   Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q [J].
Elmslie, FV ;
Rees, M ;
Williamson, MP ;
Kerr, M ;
Kjeldsen, MJ ;
Pang, KA ;
Sundqvist, A ;
Friis, ML ;
Chadwick, D ;
Richens, A ;
Covanis, A ;
Santos, M ;
Arzimanoglou, A ;
Panayiotopoulos, CP ;
Curtis, D ;
Whitehouse, WP ;
Gardiner, RM .
HUMAN MOLECULAR GENETICS, 1997, 6 (08) :1329-1334
[9]  
GELLMAN RL, 1987, J PHARMACOL EXP THER, V241, P891
[10]   Monogenic idiopathic epilepsies [J].
Gourfinkel-An, I ;
Baulac, S ;
Nabbout, R ;
Ruberg, M ;
Baulac, M ;
Brice, A ;
LeGuern, E .
LANCET NEUROLOGY, 2004, 3 (04) :209-218